Antithrombotic therapy in acute ischaemic stroke: An overview of the completed randomised trials

Journal of Neurology Neurosurgery and Psychiatry

Volumn 56, Issue 1, 1993, Pages 17-25

  Sandercock, P A G ^a   Van den Belt, A G M ^a   Lindley, R I ^a   Slattery, J ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; DIPYRIDAMOLE; HEPARIN; PHENINDIONE; STREPTOKINASE; TICLOPIDINE; WARFARIN;

ACUTE HEART INFARCTION; ARTICLE; BRAIN HEMORRHAGE; BRAIN INFARCTION; CEREBROVASCULAR ACCIDENT; DEATH; DEEP VEIN THROMBOSIS; DISABILITY; DRUG EFFICACY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG EMBOLISM; MORTALITY; ORAL DRUG ADMINISTRATION; PHLEBOGRAPHY; PRIORITY JOURNAL; RISK FACTOR; STATISTICS; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0027418704     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.56.1.17     Document Type: Article

References (32)

1. Broderick, J.P.; Phillips, S.J.; Whisnant, J.P.; O'Fallon, W.M.; Bergstralh, E.J. Incidence rates of stroke in the eighties: the end of the decline in stroke? Stroke 1989 10.1161/01.STR.20.5.577 20 577
2. Homer, D.; Whisnant, J.P.; Schoenberg, B.S. Trends in the incidence rates of stroke in Rochester, Minnesota, since 1935 Ann Neurol 1987 10.1002/ana.410220209 22 245
3. Theroux, P.; Ouimet, H.; McCans, J. or both to treat acute unstable angina N Engl Med 1988 10.1056/NEJM198810273191701 319 1105
4. Cairns, J.A. Clinical trials of antiplatelet drug therapy in acute myocardial infarction, unstable angina, and aortocoronary bypass surgery Cardiovasc Clin 1987 18 231
5. Lewis, H.D.; Davis, J.W.; Archibald, D.G. et aL Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study N Engl Med 1983 10.1056/NEJM198308183090703 309 396
6. Turpie, A.G.G.; Robinson, J.G.; Doyle, D.J. Comparison of high-dose with low-dose subcutaneous heparin to prevent left ventricular mural thrombosis in patients with acute transmural anterior myocardial infarction N Engl Med 1989 10.1056/NEJM198902093200604 320 352
7. Salzman, E.W.; Harris, W.H. Acetylsalicylic acid for the prevention of venous thromboembolic disease in surgical patients 1982 225 acid: new uses for an old drug
8. Collins, R.; ScrimgeourA, Yusuf; S, Peto; R. Reduction in fatalpulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin N Engl Med 1988 318 162 1
9. Yusuf, S.; Wittes, J.; Friedman, L. Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarction JAMA 1988 10.1001/jama.1988.03410140100032 260 2088
10. Yusuf, S.; Collins, R.; Peto, R. Why do we need some large, simple randomised trials? Stat Med 1984 10.1002/sim.4780030421 3 409
11. YusufS, Peto R.; J, Lewis; R, Collins; P, Sleight Beta blockade during and after myocardial infarction: an overview of the randomised trials Prog Cardiovasc Dis 1985 10.1016/S0033-0620(85)80003-7 27 335
12. Duke, R.J.; Bloch, R.F.; Turpie, A.G.G.; Trebilcock, R.; Bayer, N. Intravenous heparin for the prevention of stroke progression in acute partial stable stroke Ann Intern Med 1986 10.7326/0003-4819-105-6-825 105 825
13. McCarthy, S.T.; Turner, J. Low-dose subcutaneous heparin in the prevention of deep-vein thrombosis and pulmonary emboli following acute stroke Age Ageing 1986 10.1093/ageing/15.2.84 15 84
14. McCarthy, S.T.; Robertson, D.; Turner, J.J.; Hawkey, C.J. Low dose heparin as a prophylaxis against deep-vein thrombosis after acute stroke Lancet 1977 2 800
15. Czechanowski, B.; Heinrich, F. Prophylaxe venoser thrombosen bei frischem ischamischem zerebrovaskularem insultdoppel-blindstudie mit heparin-dihydergot Dtsch Med Wochenschr 1981 10.1055/s-2008-1070492 106 1254
16. Duke, R.J.; Turpie, A.G.; Bloch, R.F.; Trebilcock, R.G. Clinical trial of low-dose subcutaneous heparin for the prevention of stroke progression: natural history of acute partial stroke and stroke-in-evolution 1983 399
17. Turpie, A.G.; Levine, M.N.; Hirsh, J. Double-blind randomised trial of Org 10172 low-molecular-weight heparinoid in prevention of deep-vein thrombosis in thrombotic stroke Lancet 1987 10.1016/S0140-6736(87)90173-5 1 523
18. Prins, M.H.; Gelsema, R.; Sing, A.K.; van Heerde, L.R.; den Ottolander, G.J.H. Prophylaxis of deep venous thrombosis with a low-molecular-weight heparin (Kabi 2165/Fragmin) in stroke patients Haemostasis 1989 19 245
19. Sandset, P.M.; Dahl, T.; Stiris, M.; Rostad, B.; Scheel, B.; Abildgaard, U. A double-blind and randomised placebocontrolled trial of low molecular weight heparin once daily to prevent deep-vein thrombosis in acute ischaemic stroke. Seminars in thrombosis and hemostasis 1990;(suppl 16) 25
20. Elias, A.; Milandre, L.; Lagrange, G. et aL Prevention of deep venous thrombosis of the leg by a very low molecular weight heparin fraction (CY 222) in patients with hemiplegia following cerebral infarction: a randomized pilot study 1990 Rev Med Interne 11 95
21. Marshall, J.; Shaw, D.A. Anticoagulant therapy in acute cerebrovascular accidents: a controlled trial Lancet 1960 10.1016/S0140-6736(60)90885-0 995
22. Dickmann, U.; Voth, E.; Schicha, H.; Henze, T.; Prange, H.; Emrich, D. Heparin therapy, deep vein thrombosis and pulmonary embolism after intracerebral haemorrhage Klin Wochenschr 1988 10.1007/BF01727666 66 1182
23. Utsumi, H. Evaluation of the utility of ticlopidine, an antiplatelet agent, for acute cerebral infarction (Sanofi technical report) 1990
24. Joseph, R.; Welch, K.M.; D'Andrea, G. Effect of therapy on platelet activating factor-induced aggregation in acute stroke Stroke 1989 10.1161/01.STR.20.5.609 20 609
25. Ciuffetti, G.; Aisa, G.; Mercuri, M.; Lombardini, R.; Paltriccia, R.; Neri, C.; Senin, U. Effects of ticlopidine on the neurologic outcome and the hemorheologic pattem in the postacute phase of ischaemic stroke: a pilot study Angiology 1990 10.1177/000331979004100701 41 505
26. Marsh, E.E.; Adams, H.P.; Biller, J.; Wasek, P.; Banwart, K.; MitchellV, Woolson; R. Use of antithrombotic drugs in the treatment of acute ischaemic stroke. A survey of neurologists in practice in the United States Neurology 1989 10.1212/WNL.39.12.1631 39 1631
27. Foulkes, M.A.; Wolf, P.A.; Price, T.R. The stroke data bank; design, methods and baseline characteristics Stroke 1988 10.1161/01.STR.19.5.547 19 547
28. Hier, D.B.; Foulkes, M.A.; Swiontoniowski, M. Stroke recurrence within 2 years after ischaemic infarction Stroke 1991 10.1161/01.STR.22.2.155 22 155
29. MacMahon, S.; Collins, R.; Knight, C. Reduction in major morbidity and mortality by heparin in acute myocardial infarction Circulation 1988 78 98
30. Levine, M.N.; Hirsh, J. Haemorrhagic complications of longterm anticoagulant therapy for ischaemic cerebral vascular disease Stroke 1986 10.1161/01.STR.17.1.111 17 111
31. Levine, M. An overview of clinical trials of low molecular weight heparin fractions Agressologie 1989 30 347
32. Jonas, S. Anticoagulant therapy in cerebrovascular disease: review and meta-analysis Stroke 1988 10.1161/01.STR.19.8.1043 19 1043